Safety and Efficacy of AFQ056 in Adult Patients With Fragile X Syndrome
Clinical trial NCT01253629 · COMPLETED
Trial details
- NCT number
- NCT01253629
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2013-08-01
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.